Accueil › Cancer du poumon non à petites cellules › Wisconsin

Essais cliniques pour Cancer du poumon non à petites cellules dans Wisconsin

45 études pour Cancer du poumon non à petites cellules recherchent des participants dans Wisconsin.

Villes dans Wisconsin

Texte officiel de l'étude (anglais)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
et 52 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
Essentia Health-Hayward Clinic, Hayward
et 2 autres

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT07293247

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Wisconsin Carbone Cancer Center, Madison

Recrutement en coursPhase 1/2

Âges de 12 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT04585750

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Local Institution - 0135, Madison

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT07680764

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #33, Milwaukee

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT05176483

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Bellin Memorial Hospital, Green Bay
Froedtert Menomonee Falls Hospital, Menomonee Falls
ProHealth D N Greenwald Center, Mukwonago
et 3 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT07388524

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Wisconsin Institute for Medical Research, Madison

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT06625775

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
Duluth Clinic Ashland, Ashland
Marshfield Medical Center-EC Cancer Center, Eau Claire
et 18 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT06498635

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

HSHS St. Vincent Hospital Regional Cancer Center, Green Bay
Local Institution - 0421, Marshfield

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 30 sept. 2026 · NCT07361510

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Milwaukee

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 29 sept. 2026 · NCT05877599

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Minnesota Oncology Hematology, P.A., Hudson
Froedtert Hospital/Medical College of Wisconsin, Milwaukee

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Mercyhealth, Janesville

Recrutement en coursPhase 3

Âges de 18 à 100 · Tous sexes · Mis à jour le 25 sept. 2026 · NCT05920356

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Milwaukee

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06218914

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Aurora Cancer Care-Grafton, Grafton
Aurora BayCare Medical Center, Green Bay
Aurora St. Luke's Medical Center, Milwaukee

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06758401

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Schofield

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06868277

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

University Hospital and UW Health Clinics, Madison
Medical College of Wisconsin, Milwaukee

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 24 sept. 2026 · NCT06890598

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Aurora Cancer Care-Southern Lakes VLCC, Burlington
Marshfield Clinic-Chippewa Center, Chippewa Falls
Aurora Saint Luke's South Shore, Cudahy
et 27 autres

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 24 sept. 2026 · NCT03191149

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Appleton

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 23 sept. 2026 · NCT06357533

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Gundersen Lutheran Medical Center, La Crosse

Recrutement en coursPhase 2/3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT06712316

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

UW Health Carbone Cancer Center, Madison

Recrutement en coursPhase 1/2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07488676

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

Medical College of Wisconsin, Milwaukee

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 18 sept. 2026 · NCT06855771

HEARTS Trial for Thoracic Cancers

University of Wisconsin - Madison, Madison

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 15 sept. 2026 · NCT07132918

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ThedaCare Regional Cancer Center, Appleton

Recrutement en coursÉtude observationnelle

Âges de 18 ans et plus · Tous sexes · Mis à jour le 14 sept. 2026 · NCT05059444

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Froedtert Hospital - Clinical Cancer Center, Milwaukee

Recrutement en coursPhase 1/2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 10 sept. 2026 · NCT06914128

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Ascension Network - St Elizabeth's Hospital, Appleton
Ascension Columbia St. Mary's, Milwaukee

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 8 sept. 2026 · NCT06793215

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Circuit Clinical/SSM Health Dean Medical Group ( Site 0129), Madison

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 8 sept. 2026 · NCT06345729

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 8 sept. 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Medical College of Wisconsin, Milwaukee

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 8 sept. 2026 · NCT06561685

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Eau Claire

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 4 sept. 2026 · NCT07291037

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

The Board of Regents of the University of Wisconsin, Madison

Recrutement en coursPhase 1/2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 sept. 2026 · NCT07070232

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Research Site, Milwaukee

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 26 août 2026 · NCT06350097

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

University of Wisconsin - Carbone Cancer Center, Madison

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 24 août 2026 · NCT06586515

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

University of Wisconsin- Madison, Madison

Recrutement en coursPhase 1/2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 11 août 2026 · NCT05592626

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Northwest Wisconsin Cancer Center, Ashland

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 14 juil. 2026 · NCT06686771

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

University of Wisconsin (Carbone Cancer Center), Madison

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 8 juin 2026 · NCT06026410

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Langlade Hospital and Cancer Center, Antigo
Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
et 27 autres

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 3 juin 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Aurora Saint Luke's South Shore, Cudahy
et 18 autres

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 6 mai 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Duluth Clinic Ashland, Ashland
Marshfield Medical Center-EC Cancer Center, Eau Claire
Gundersen Lutheran Medical Center, La Crosse
et 5 autres

Recrutement en coursPhase 2

18 Minutes · Tous sexes · Mis à jour le 5 mai 2026 · NCT06031688

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Univeristy of Wisconsin, Madison

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 5 mai 2026 · NCT04317534

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Aurora Saint Luke's South Shore, Cudahy
et 26 autres

Recrutement en coursPhase 2/3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 5 mai 2026 · NCT06616584

Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.